Delivery Order SPE2DX22D0010-SPE2D826FBY67
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Levorphanol 2 mg tablets (100-count) with a ceiling value of $2,715.74. This is a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Levorphanol Tablets 2mg, a controlled pharmaceutical product used in pain management. This firm fixed-price delivery order, valued at $8,422.31, was awarded without set-aside designation through competitive procurement and is scheduled for completion by June 25, 2025. The place of performance is AmerisourceBergen's corporate office location in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor, for the supply of Levorphanol 2 mg Tablets. The contract has a total ceiling value of $14,014.50 and a period of performance through August 15, 2024. The contract is a Firm Fixed Price type and was not set aside for any special designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,854.05 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,557.66 firm fixed-price contract is for the delivery of Levorphanol Tablets 2mg, a specialty medication, with a performance period through May 17, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,606.83 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,270.19 firm fixed-price delivery order is for LEVORPHANOL TABS 2MG, with a period of performance through March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,927.24 to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,830,114 tablets of 2 mg Levorphanol, a prescription medication, by June 7, 2024. This contract is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,202,532 units of the prescription medication Levorphanol 2 mg tablets in quantities of 100 per bottle. The contract has a firm fixed price of $1,984.51 and a completion date of May 12, 2025. This award is not associated with a set-aside program and appears to be an...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBY67Delivery Order
The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol Tablets 2mg under a firm fixed-price contract. The award, issued on December 23, 2025, carries a ceiling value of $5,270.16 and is scheduled for completion by December 24, 2025. This non-set-aside delivery order will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is well-positioned to execute this requirement as a critical vendor for federal medical procurement. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical commodities to support military healthcare programs worldwide. The firm's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products, including specialized medications and medical supplies, to Defense Health Agency and other government healthcare systems on a competitively awarded basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 12/22/25 |